肠–眼轴:眼科疾病防治的新途径
Gut-Eye Axis: A New Approach for the Prevention and Treatment of Ophthalmic Diseases
DOI: 10.12677/jcpm.2024.34299, PDF,   
作者: 顾晨浩:黑龙江中医药大学研究生院,黑龙江 哈尔滨;姚 靖*:黑龙江中医药大学附属第一医院眼科,黑龙江 哈尔滨
关键词: 肠–眼轴眼科疾病作用机制临床意义Gut-Eye Axis Ophthalmic Diseases Mechanism of Action Clinical Significance
摘要: 肠道微生物群对于宿主的健康起着十分重要的作用,其结构复杂,功能多样,并且与不同疾病的各种病理通路有关,故而受到了广泛的研究。近期,越来越多的研究结果表明,肠道微生物群与眼部健康之间存在着重要的关联,肠–眼轴这一概念也随之兴起。本综述基于PubMed、中国知网、万方数据库、维普网上以“肠–眼轴”为主题的论文,研究了已发表的关于肠道微生物群与眼部发病之间关系的研究结果,阐述并总结肠–眼轴的存在参与了一些眼部疾病的发病机制,包括青光眼、高度近视、干眼症、自身免疫性葡萄膜炎、年龄相关性黄斑变性、糖尿病视网膜病变、细菌性角膜炎。了解肠道微生物群与上述眼部疾病之间的联系,有助于开发新的治疗方法,例如益生菌、益生元或粪便微生物群移植。总之,肠–眼轴为眼科疾病的研究和防治提供了新的视角和方向。
Abstract: The gut microbiota plays a very important role in the health of the host. It has a complex structure and diverse functions and is related to various pathological pathways of different diseases, so it has received extensive research. Recently, more and more research results have shown that there is an important correlation between the gut microbiota and eye health, and the concept of the gut-eye axis has also emerged. This review is based on papers on “gut-eye axis” in PubMed, CNKI, Wanfang Database, and VIP database. It studies the published research results on the relationship between the gut microbiota and the onset of eye diseases, and expounds and summarizes that the existence of the gut-eye axis is involved in the pathogenesis of some eye diseases, including glaucoma, high myopia, dry eye, autoimmune uveitis, age-related macular degeneration, diabetic retinopathy, bacterial keratitis. Understanding the connection between the gut microbiota and the above eye diseases will help develop new treatment methods, such as probiotics, prebiotics, or fecal microbiota transplantation. In short, the gut-eye axis provides a new perspective and direction for the research and prevention of ophthalmic diseases.
文章引用:顾晨浩, 姚靖. 肠–眼轴:眼科疾病防治的新途径[J]. 临床个性化医学, 2024, 3(4): 2112-2119. https://doi.org/10.12677/jcpm.2024.34299

参考文献

[1] Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G.A.D., Gasbarrini, A., et al. (2019) What Is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7, Article No. 14. [Google Scholar] [CrossRef] [PubMed]
[2] Thursby, E. and Juge, N. (2017) Introduction to the Human Gut Microbiota. Biochemical Journal, 474, 1823-1836. [Google Scholar] [CrossRef] [PubMed]
[3] Donabedian, P., Dawson, E., Li, Q. and Chen, J. (2021) Gut Microbes and Eye Disease. Ophthalmic Research, 65, 245-253. [Google Scholar] [CrossRef] [PubMed]
[4] Shivaji, S. (2017) We Are Not Alone: A Case for the Human Microbiome in Extra Intestinal Diseases. Gut Pathogens, 9, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
[5] Chen, N., Wu, J., Wang, J., Piri, N., Chen, F., Xiao, T., et al. (2021) Short Chain Fatty Acids Inhibit Endotoxin-Induced Uveitis and Inflammatory Responses of Retinal Astrocytes. Experimental Eye Research, 206, Article ID: 108520. [Google Scholar] [CrossRef] [PubMed]
[6] Nakamura, Y.K., Janowitz, C., Metea, C., Asquith, M., Karstens, L., Rosenbaum, J.T., et al. (2017) Short Chain Fatty Acids Ameliorate Immune-Mediated Uveitis Partially by Altering Migration of Lymphocytes from the Intestine. Scientific Reports, 7, Article No. 11745. [Google Scholar] [CrossRef] [PubMed]
[7] Hofmann, A.F. and Hagey, L.R. (2014) Key Discoveries in Bile Acid Chemistry and Biology and Their Clinical Applications: History of the Last Eight Decades. Journal of Lipid Research, 55, 1553-1595. [Google Scholar] [CrossRef] [PubMed]
[8] Lobysheva, E., Taylor, C.M., Marshall, G.R. and Kisselev, O.G. (2018) Tauroursodeoxycholic Acid Binds to the G-Protein Site on Light Activated Rhodopsin. Experimental Eye Research, 170, 51-57. [Google Scholar] [CrossRef] [PubMed]
[9] Lima Barrientos, J., Rojas Huerta, A., Perez Mendoza, A., Abreu Lopez, B.A., Salolin Vargas, V.P., Garcia Gonzalez, O.Y., et al. (2024) The Relationship between Gut Microbiome and Ophthalmologic Diseases: A Comprehensive Review. Cureus, 16, e66808. [Google Scholar] [CrossRef] [PubMed]
[10] Moon, J., Yoon, C.H., Choi, S.H. and Kim, M.K. (2020) Can Gut Microbiota Affect Dry Eye Syndrome? International Journal of Molecular Sciences, 21, Article No. 8443. [Google Scholar] [CrossRef] [PubMed]
[11] Vavricka, S.R., Schoepfer, A., Scharl, M., Lakatos, P.L., Navarini, A. and Rogler, G. (2015) Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 21, 1982-1992. [Google Scholar] [CrossRef] [PubMed]
[12] Hu, J., Chen, J., Xu, X., Hou, Q., Ren, J. and Yan, X. (2023) Gut Microbiota-Derived 3-Phenylpropionic Acid Promotes Intestinal Epithelial Barrier Function via Ahr Signaling. Microbiome, 11, Article No. 102. [Google Scholar] [CrossRef] [PubMed]
[13] McGeachy, M.J., Chen, Y., Tato, C.M., Laurence, A., Joyce-Shaikh, B., Blumenschein, W.M., et al. (2009) The Interleukin 23 Receptor Is Essential for the Terminal Differentiation of Interleukin 17-Producing Effector T Helper Cells in Vivo. Nature Immunology, 10, 314-324. [Google Scholar] [CrossRef] [PubMed]
[14] He, C., Xiu, W., Chen, Q., Peng, K., Zhu, X., Wang, Z., et al. (2023) Gut-Licensed β7+ CD4+ T Cells Contribute to Progressive Retinal Ganglion Cell Damage in Glaucoma. Science Translational Medicine, 15, eadg1656. [Google Scholar] [CrossRef] [PubMed]
[15] Chen, J., Chen, D.F. and Cho, K. (2023) The Role of Gut Microbiota in Glaucoma Progression and Other Retinal Diseases. The American Journal of Pathology, 193, 1662-1668. [Google Scholar] [CrossRef] [PubMed]
[16] Vergroesen, J.E., Jarrar, Z.A., Weiss, S., Frost, F., Ansari, A.S., Nguyen, P., et al. (2024) Glaucoma Patients Have a Lower Abundance of Butyrate-Producing Taxa in the Gut. Investigative Opthalmology & Visual Science, 65, Article No. 7. [Google Scholar] [CrossRef] [PubMed]
[17] Li, H., Du, Y., Cheng, K., Chen, Y., Wei, L., Pei, Y., et al. (2024) Gut Microbiota-Derived Indole-3-Acetic Acid Suppresses High Myopia Progression by Promoting Type I Collagen Synthesis. Cell Discovery, 10, Article No. 89. [Google Scholar] [CrossRef] [PubMed]
[18] 亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识: 定义和分类(2020年) [J]. 中华眼科杂志, 2020, 56(6): 418-422.
[19] Schaefer, L., Hernandez, H., Coats, R.A., Yu, Z., Pflugfelder, S.C., Britton, R.A., et al. (2022) Author Correction: Gut-Derived Butyrate Suppresses Ocular Surface Inflammation. Scientific Reports, 12, Article No. 6581. [Google Scholar] [CrossRef] [PubMed]
[20] de Paiva, C.S., Jones, D.B., Stern, M.E., Bian, F., Moore, Q.L., Corbiere, S., et al. (2016) Altered Mucosal Microbiome Diversity and Disease Severity in Sjögren Syndrome. Scientific Reports, 6, Article No. 23561. [Google Scholar] [CrossRef] [PubMed]
[21] Huang, X., Ye, Z., Cao, Q., Su, G., Wang, Q., Deng, J., et al. (2018) Gut Microbiota Composition and Fecal Metabolic Phenotype in Patients with Acute Anterior Uveitis. Investigative Opthalmology & Visual Science, 59, 1523-1531. [Google Scholar] [CrossRef] [PubMed]
[22] Janetos, T.M., Zakaria, N. and Goldstein, D.A. (2023) The Microbiome and Uveitis. The American Journal of Pathology, 193, 1638-1647. [Google Scholar] [CrossRef] [PubMed]
[23] Vavricka, S.R., Brun, L., Ballabeni, P., Pittet, V., Vavricka, B.M.P., Zeitz, J., et al. (2011) Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort. American Journal of Gastroenterology, 106, 110-119. [Google Scholar] [CrossRef] [PubMed]
[24] Nakamura, Y.K., Metea, C., Karstens, L., Asquith, M., Gruner, H., Moscibrocki, C., et al. (2016) Gut Microbial Alterations Associated with Protection from Autoimmune Uveitis. Investigative Opthalmology & Visual Science, 57, 3747-3758. [Google Scholar] [CrossRef] [PubMed]
[25] Kim, J., Choi, S., Kim, Y., Jeong, H., Ryu, J., Lee, H., et al. (2017) Clinical Effect of IRT-5 Probiotics on Immune Modulation of Autoimmunity or Alloimmunity in the Eye. Nutrients, 9, Article No. 1166. [Google Scholar] [CrossRef] [PubMed]
[26] Zinkernagel, M.S., Zysset-Burri, D.C., Keller, I., Berger, L.E., Leichtle, A.B., Largiadèr, C.R., et al. (2017) Association of the Intestinal Microbiome with the Development of Neovascular Age-Related Macular Degeneration. Scientific Reports, 7, Article ID: 740826. [Google Scholar] [CrossRef] [PubMed]
[27] Andriessen, E.M., Wilson, A.M., Mawambo, G., Dejda, A., Miloudi, K., Sennlaub, F., et al. (2016) Gut Microbiota Influences Pathological Angiogenesis in Obesity‐Driven Choroidal Neovascularization. EMBO Molecular Medicine, 8, 1366-1379. [Google Scholar] [CrossRef] [PubMed]
[28] Tanase, D.M., Gosav, E.M., Neculae, E., Costea, C.F., Ciocoiu, M., Hurjui, L.L., et al. (2020) Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM). Nutrients, 12, Article No. 3719. [Google Scholar] [CrossRef] [PubMed]
[29] Jiao, J., Yu, H., Yao, L., Li, L., Yang, X. and Liu, L. (2021) Recent Insights into the Role of Gut Microbiota in Diabetic Retinopathy. Journal of Inflammation Research, 14, 6929-6938. [Google Scholar] [CrossRef] [PubMed]
[30] Liu, K., Zou, J., Fan, H., Hu, H. and You, Z. (2022) Causal Effects of Gut Microbiota on Diabetic Retinopathy: A Mendelian Randomization Study. Frontiers in Immunology, 13, Article ID: 930318. [Google Scholar] [CrossRef] [PubMed]
[31] Hong, J., Fu, T., Liu, W., Du, Y., Min, C. and Lin, D. (2022) Specific Alterations of Gut Microbiota in Diabetic Microvascular Complications: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology, 13, Article ID: 1053900. [Google Scholar] [CrossRef] [PubMed]
[32] Zhang, H. and Mo, Y. (2023) The Gut-Retina Axis: A New Perspective in the Prevention and Treatment of Diabetic Retinopathy. Frontiers in Endocrinology, 14, Article ID: 1205846. [Google Scholar] [CrossRef] [PubMed]
[33] Kugadas, A., Christiansen, S.H., Sankaranarayanan, S., Surana, N.K., Gauguet, S., Kunz, R., et al. (2016) Impact of Microbiota on Resistance to Ocular Pseudomonas Aeruginosa-Induced Keratitis. PLOS Pathogens, 12, e1005855. [Google Scholar] [CrossRef] [PubMed]
[34] Hatziioanou, D., Gherghisan-Filip, C., Saalbach, G., Horn, N., Wegmann, U., Duncan, S.H., et al. (2017) Discovery of a Novel Lantibiotic Nisin O from Blautia Obeum A2-162, Isolated from the Human Gastrointestinal Tract. Microbiology, 163, 1292-1305. [Google Scholar] [CrossRef] [PubMed]
[35] Guo, Y., Luo, S., Ye, Y., Yin, S., Fan, J. and Xia, M. (2020) Intermittent Fasting Improves Cardiometabolic Risk Factors and Alters Gut Microbiota in Metabolic Syndrome Patients. The Journal of Clinical Endocrinology & Metabolism, 106, 64-79. [Google Scholar] [CrossRef] [PubMed]
[36] 戴诗睿. 益生菌和益生元通过肠眼轴改善2型糖尿病小鼠干眼[D]: [博士学位论文]. 长沙: 中南大学, 2023.